SION · Sionna Therapeutics, Inc. · Held by Funds
The latest filing states the doubt was alleviated.
“The Company has evaluated whether there are conditions and events, considered in the aggregate, that raise substantial doubt about the Company’s ability to continue as a going concern within one year after the date that these condensed consolidated financial statements are issued. The Company believes that its existing cash, cash equivalents and marketable securities of $268.3 million as of June 30, 2026, will be sufficient to allow the Company to fund operations beyond twelve months from the date that the financial statements are issued.”View the 10-Q filed Aug 6, 2026
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Registered funds — mutual funds, ETFs and closed-end funds — whose latest Form N-PORT portfolio report holds this exact listed security, matched by CUSIP. Each row is one fund position with its size, value and weight in that fund.
Fund Ownership of SION by Fund Type
Registered funds' Form N-PORT reports for the quarter ended Jun 30, 2026Index funds and index ETFs hold 7.74% of shares outstanding.
| Fund type | Of shares outstanding | Shares |
|---|---|---|
| Index funds | 1.30% | 589,199 |
| Index ETFs | 6.43% | 2,910,114 |
| Active ETFs | 0.13% | 58,706 |
| Active funds | 6.42% | 2,905,702 |
| Unclassified | 0.24% | 106,290 |
| All registered funds | 14.52% | 6,570,011 |
How fund types are measured
Each fund series counts once, with its latest Form N-PORT report dated inside the quarter; only long share positions count, restated to today's split basis. The fund type is the series' latest Form N-CEN answer on or before the quarter end (the index-fund box and the exchange-traded flag), never its name. Unclassified funds have no usable N-CEN; unit investment trusts are among them, so index ownership is a floor. Funds sit inside their advisers' 13F reports, so these shares overlap the 13F figures and are never added to them.
Funds holding SION
136 fund positions| Fund | Ticker | Balance | Value | % of Fund | Side | Reported | Open |
|---|---|---|---|---|---|---|---|
| VANGUARD TOTAL STOCK MARKET INDEX FUND | — | 934,641 | $41,114,858 | 0.00% | Long | 2026-06-30 | |
| State Street(R) SPDR(R) S&P(R) Biotech ETF | XBI | 647,694 | $28,492,059 | 0.27% | Long | 2026-06-30 | |
| JPMorgan Small Cap Growth Fund | — | 524,280 | $23,063,077 | 0.88% | Long | 2026-06-30 | |
| iShares Russell 2000 ETF | IWM | 483,961 | $21,289,444 | 0.03% | Long | 2026-06-30 | |
| Eventide Healthcare & Life Sciences Fund | — | 474,969 | $20,893,886 | 1.17% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Fund, Inc. | — | 287,643 | $12,653,416 | 0.11% | Long | 2026-06-30 | |
| Fidelity Small Cap Index Fund | FSSNX | 201,838 | $9,512,625 | 0.03% | Long | 2026-07-31 | |
| abrdn Healthcare Investors | HQH | 201,736 | $8,874,367 | 0.65% | Long | 2026-06-30 | |
| iShares Biotechnology ETF | IBB | 185,693 | $8,168,635 | 0.09% | Long | 2026-06-30 | |
| iShares Russell 2000 Growth ETF | IWO | 173,168 | $7,617,660 | 0.05% | Long | 2026-06-30 | |
| VANGUARD EXTENDED MARKET INDEX FUND | — | 168,369 | $7,406,552 | 0.01% | Long | 2026-06-30 | |
| JPMorgan Small Cap Blend Fund | — | 166,643 | $7,330,626 | 0.43% | Long | 2026-06-30 | |
| PGIM Jennison Health Sciences Fund | — | 933,570 | $5,629,427 | 0.38% | Long | 2026-08-31 | |
| Artisan International Small-Mid Fund | — | 116,442 | $5,122,284 | 0.20% | Long | 2026-06-30 | |
| Franklin Biotechnology Discovery Fund | — | 107,956 | $5,087,966 | 0.44% | Long | 2026-07-31 | |
| abrdn Life Sciences Investors | HQL | 82,402 | $3,624,864 | 0.53% | Long | 2026-06-30 | |
| T. Rowe Price New Horizons Fund, Inc. | — | 70,768 | $3,113,084 | 0.02% | Long | 2026-06-30 | |
| Schwab Small-Cap Index Fund | SWSSX | 44,674 | $2,105,486 | 0.03% | Long | 2026-07-31 | |
| Driehaus Micro Cap Growth Fund | DMCRX | 46,945 | $2,065,111 | 0.35% | Long | 2026-06-30 | |
| Master Small Cap Index Series | — | 34,469 | $1,516,291 | 0.03% | Long | 2026-06-30 | |
| Nuveen Small Cap Blend Index Fund | — | 24,424 | $1,151,103 | 0.03% | Long | 2026-07-31 | |
| Direxion Daily S&P Biotech Bull 3X Shares | LABU | 22,009 | $1,037,284 | 0.21% | Long | 2026-07-31 | |
| iShares Core S&P Total U.S. Stock Market ETF | ITOT | 21,536 | $947,369 | 0.00% | Long | 2026-06-30 | |
| EQ/2000 Managed Volatility Portfolio | — | 20,147 | $886,267 | 0.02% | Long | 2026-06-30 | |
| T. Rowe Price Health Sciences Portfolio | — | 17,807 | $783,330 | 0.10% | Long | 2026-06-30 | |
| EQ/Small Company Index Portfolio | — | 17,790 | $782,582 | 0.04% | Long | 2026-06-30 | |
| Fidelity Small Cap Growth Index Fund | FECGX | 17,278 | $760,059 | 0.05% | Long | 2026-06-30 | |
| VANGUARD BALANCED INDEX FUND | — | 14,944 | $657,387 | 0.00% | Long | 2026-06-30 | |
| LVIP Franklin Templeton Multi-Factor SMID Cap Equity Fund | — | 14,508 | $638,207 | 0.06% | Long | 2026-06-30 | |
| VANGUARD RUSSELL 2000 INDEX FUND | — | 105,529 | $636,340 | 0.00% | Long | 2026-08-31 | |
| VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND | — | 14,099 | $620,215 | 0.00% | Long | 2026-06-30 | |
| Nuveen Equity Index Fund | — | 12,533 | $590,680 | 0.00% | Long | 2026-07-31 | |
| LVIP State Street Small-Cap Index Fund | — | 13,200 | $580,668 | 0.03% | Long | 2026-06-30 | |
| Schwab U.S. Small-Cap ETF | SCHA | 69,261 | $417,644 | 0.00% | Long | 2026-08-31 | |
| Global X Russell 2000 ETF | RSSL | 8,820 | $415,687 | 0.03% | Long | 2026-07-31 | |
| Schwab Total Stock Market Index Fund | SWTSX | 8,762 | $412,953 | 0.00% | Long | 2026-07-31 | |
| Small Cap Index Fund | NSIDX | 9,298 | $409,019 | 0.02% | Long | 2026-06-30 | |
| Virtus Biotech Clinical Trials Etf | BBC | 8,653 | $407,816 | 0.88% | Long | 2026-07-31 | |
| U.S. Small Cap Equity Fund | — | 8,456 | $398,531 | 0.04% | Long | 2026-07-31 | |
| Fidelity ZERO Total Market Index Fund | FZROX | 7,675 | $361,723 | 0.00% | Long | 2026-07-31 | |
| ALPS Medical Breakthroughs ETF | SBIO | 55,581 | $335,153 | 0.14% | Long | 2026-08-31 | |
| Fidelity MSCI Health Care Index ETF | FHLC | 6,417 | $302,433 | 0.01% | Long | 2026-07-31 | |
| BIOTECHNOLOGY ULTRASECTOR PROFUND | — | 6,176 | $291,075 | 0.25% | Long | 2026-07-31 | |
| Blackstone Alternative Multi-Strategy Fund | — | 6,575 | $289,234 | 0.01% | Long | 2026-06-30 | |
| Health Sciences Trust | — | 6,272 | $275,905 | 0.11% | Long | 2026-06-30 | |
| MetLife Russell 2000 Index Portfolio | — | 6,220 | $273,618 | 0.03% | Long | 2026-06-30 | |
| STATE STREET SMALL/MID CAP EQUITY INDEX PORTFOLIO | SSMHX | 6,100 | $268,339 | 0.01% | Long | 2026-06-30 | |
| Fidelity ZERO Extended Market Index Fund | FZIPX | 5,454 | $257,047 | 0.01% | Long | 2026-07-31 | |
| VANGUARD HEALTH CARE INDEX FUND | — | 41,122 | $247,966 | 0.00% | Long | 2026-08-31 | |
| JPMorgan BetaBuilders U.S. Small Cap Equity ETF | BBSC | 5,243 | $247,103 | 0.04% | Long | 2026-07-31 |